Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2025-12-24 @ 7:44 PM
NCT ID:
NCT02300103
Eligibility Criteria:
Key Inclusion Criteria:
* Willing and able to provide written informed consent
* HCV genotype determined by the Central Laboratory
* HCV RNA \> LLOQ at screening
* Participated and completed a Gilead sponsored HCV treatment study of direct acting antiviral (DAA) containing regimens.
* Male and female of childbearing potential must agree to use protocol specified method(s) of contraception
Key Exclusion Criteria:
* Current or prior history: Clinically-significant illness (other than HCV) or any other major medical disorder that may interfere with treatment, assessment or compliance with the protocol; individuals currently under evaluation for a potentially clinically-significant illness (other than HCV) are also excluded.
* Screening ECG with clinically significant abnormalities
* Laboratory results outside of acceptable ranges at screening
* Infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV)
NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02300103
Study Brief:
Protocol Section:
NCT02300103